ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 174 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,131,769 | -83.2% | 30,296 | -84.1% | 0.00% | -87.0% |
| Q1 2021 | $24,603,000 | +13.0% | 190,900 | +46.3% | 0.02% | 0.0% |
| Q4 2020 | $21,765,000 | +10.2% | 130,500 | +2.0% | 0.02% | 0.0% |
| Q3 2020 | $19,753,000 | +26.0% | 128,000 | +20.8% | 0.02% | +21.1% |
| Q2 2020 | $15,677,000 | +134.0% | 106,000 | +78.2% | 0.02% | +90.0% |
| Q1 2020 | $6,700,000 | -25.5% | 59,500 | -8.0% | 0.01% | 0.0% |
| Q4 2019 | $8,997,000 | +882.2% | 64,669 | +361.9% | 0.01% | +900.0% |
| Q1 2018 | $916,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |